(Q54191926)

26 May 2018

title

MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. (English)

1 reference

26 May 2018

1 reference

hepatocellular carcinoma

1 reference

6

1 reference

26 May 2018

author name string

Binkui Li

1

1 reference

26 May 2018

Pinzhu Huang

2

1 reference

26 May 2018

Jiliang Qiu

3

1 reference

26 May 2018

Yadi Liao

4

1 reference

26 May 2018

Jian Hong

5

1 reference

26 May 2018

publication date

14 September 2014

1 reference

26 May 2018

published in

Medical Oncology

1 reference

26 May 2018

volume

31

1 reference

26 May 2018

issue

10

1 reference

26 May 2018

page(s)

230

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-014-0230-2

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Strategies for the management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Current strategy for staging and treatment: the BCLC update and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Hepatocellular carcinoma: clinical frontiers and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Molecular mechanisms of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

microRNAs in cancer management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0230-2

Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications

1 reference

12 December 2020

Tumor markers for hepatocellular carcinoma (Review)

1 reference

12 December 2020

Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma

1 reference

12 December 2020

miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222

1 reference

12 December 2020

MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines

1 reference

12 December 2020

Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

1 reference

12 December 2020

10.1007/S12032-014-0230-2

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

25218269

1 reference

26 May 2018